During the past decade, Lake Washington Vascular, Pllc conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 14 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 10 clinical trials were completed. i.e. 333.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lake Washington Vascular, Pllc" #1 sponsor was "Medtronic Endovascular" with 4 trials, followed by "Lake Washington Vascular" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "C. R. Bard" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lake Washington Vascular, Pllc" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "Medtronic Vascular" with 1 trials as a collaborator, "Sapheon, Inc." with 1 trials as a collaborator and "Syntactx" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Lake Washington Vascular, Pllc" are "Venous Reflux" (4 trials), "Peripheral Arterial Disease" (3 trials), "Varicose Veins" (3 trials), "Chronic Kidney Disease" (2 trials) and "Great Saphenous Vein (GSV) With Venous Reflux Disease" (2 trials). Many other conditions were trialed in "Lake Washington Vascular, Pllc" in a lesser frequency.

Most popular intervention types in "Lake Washington Vascular, Pllc" are "Device" (12 trials), "Drug" (7 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ClosureFast Radiofrequency Ablation (RFA)" (2 trials), "VenaSeal SCS" (2 trials), "Abre venous self-expanding stent system" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lake Washington Vascular, Pllc" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Lake Washington Vascular, Pllc". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Lake Washington Vascular, Pllc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lake Washington Vascular, Pllc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".